42 Robots AI
Founded in 2024, 42 Robots AI's headquarters are in Dallas, TX, and employs around 14 people. The company is part of the Software and AI vertical at IPO CLUB.
What is 42 Robots AI?
42 Robots AI is a Healthcare Technology and AI-Driven Patient Support Services company with the vision to leverage cutting-edge AI technology to significantly enhance patients' quality of life by providing vital information, emotional support, and practical assistance during their most vulnerable times. We aim to empower patients, foster hope, and improve end-of-life care through innovative AI solutions at a minimal monthly cost.
Problem
Today, doctors are stressed and overworked and often need more specialized skills to manage terminal patients effectively. Concurrently, trials, studies, and research are conducted globally around the clock, leading to continuous new solutions and discoveries. Patients need assistance to navigate this vast and complex information landscape, missing critical opportunities for improved care and support. The overwhelming flood of information, coupled with insecurity, emotions, and fear, leaves patients feeling lost and unsupported during their most vulnerable times.
Solution
To address these challenges, our AI agent offers a comprehensive support system tailored for terminally ill patients. It provides personalized, up-to-date medical information and resources, helping patients navigate the complex landscape of global research and clinical trials. By offering emotional support and practical assistance, the AI agent alleviates the burden on overworked healthcare providers and ensures patients receive consistent, compassionate care. This technology empowers patients to make informed decisions, reduces their insecurity and fear, and enhances their overall quality of life during their most vulnerable times.
MVP
42 Robots’ agent is an all-in-one AI Medical Assistant designed to save cancer patients' lives, providing vital information, emotional support, and practical help during their most vulnerable times. The main deliverable of the agent is to perform time-consuming tasks such as constantly researching medical sources of information on the latest trials and treatments, providing a pre-visit list of questions for the patient’s doctors, and in between checklists, summaries, and reference information.
Anduril stock price source: IPO CLUB Valuation at Market©
User Benefits
● Saves hours daily because 42 Robots.ai agents will do time-consuming tasks for you
● Decreasing human error: Get life-saving suggestions to discuss during your next doctor’s appointment.
● Increase life quality because 42 Robots.ai provides emotional support and practical assistance.
● Feel empowered as 42 Robots.ai allows informed decisions and reduces their feelings of insecurity and fear.
● Do impossible tasks, like monitoring hundreds of online medical sources on the condition, treatments, and trials.
● Eliminate uncertainty because 42 Robots.ai finds, catalogs, formats, and explains medical information in an easy-to-access and understandable format.
Sign up for the trial
Become a member for in-depth coverage of 42 Robots AI
Market
42 Robots.ai MVP is designed for cancer patients.
In 2022, there were an estimated 20 million new cancer cases globally, with 9.7 million deaths attributed to cancer. The number of cancer survivors worldwide within five years following a diagnosis was approximately 53.5 million.
In 2024, the United States is expected to see over two million new cancer cases for the first time, translating to approximately 5,500 new diagnoses each day. This significant increase is driven by the aging population and rising incidences of common cancers such as breast, prostate, endometrial, pancreatic, kidney, and melanoma.
Moreover, as of January 2022, there were an estimated 18.1 million cancer survivors in the U.S., with this number projected to rise to 22.5 million by 2032.
Latest news
Stay up-to-date with all the latest news about 42 Robots AI, the IPO, and investment opportunities. By clicking here, you'll access real-time updates and in-depth analysis from market experts, empowering you to make informed decisions about your investment journey. Whether you're a seasoned investor or just getting started, our platform is tailored to provide you with all the crucial information you need to navigate the thrilling world of the stock market and IPOs. Dive in and keep your finger on the pulse of the financial markets.
